United States · FDA National Drug Code directory
RHAPSIDO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0078-1483_9e44a793-9940-4ae3-9fe6-0f901afa37e0
- Product NDC
- 0078-1483
- Form
- TABLET
- Composition / generic term
- remibrutinib
- Labeler
- Novartis Pharmaceuticals Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250930
- Source listing expiry
- 20271231
Source-listed ingredients
- REMIBRUTINIB — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE (0078-1483-20) · 0078-1483-20
- 2 BOTTLE in 1 CARTON (0078-1483-92) / 30 TABLET in 1 BOTTLE · 0078-1483-92
- 30 TABLET in 1 BOTTLE (0078-1483-93) · 0078-1483-93
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →